LRG-47 Antibodies

Santa Cruz Biotechnology provides a broad selection of LRG-47 monoclonal antibodies for research focused on understanding LRG-47's role in various biological processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRG-47, also known as leucine-rich alpha-2-glycoprotein 1, plays a critical role in immune response and inflammation. Research has shown LRG-47's involvement in regulating immune cell activity, with significant implications in cancer and autoimmune disorders. Understanding LRG-47's function continues to reveal its potential as a biomarker and therapeutic target. Researchers worldwide utilize LRG-47 monoclonal antibodies to advance their studies in immunology and disease mechanisms. The specificity and reliability of LRG-47 monoclonal antibodies enable precise detection and analysis of protein expression patterns. Current investigations focus on uncovering new pathways and mechanisms associated with LRG-47's biological functions. Santa Cruz Biotechnology monoclonal antibodies for LRG-47 support the scientific community in advancing our understanding of immune system regulation and disease development.